MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Cancer Treatment and Pharmacology
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,351 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,351 works in the cohort · of 4,299,418page 2 of 28

Labels cover 6 of 1,351 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,351 of 1,351 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Lessons learned from independent central review
Robert Ford, Lawrence H. Schwartz, Janet Dancey, Lori E. Dodd, E. Eisenhauer, Stephen J. Gwyther +5 more
2008· article· en· European Journal of Cancer· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
115
citations
affunlabeled
The Next 100 Years of Polymer Science
Alaa S. Abd‐El‐Aziz, Markus Antonietti, Christopher Barner‐Kowollik, Wolfgang H. Binder, Alexander Böker, Cyrille Boyer +48 more
2020· article· en· Macromolecular Chemistry and Physics· Medicine
distilled prediction:candidate · noneconsensus · none
108
citations
affunlabeled
Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis
Gerald Batist, Lyndsay N. Harris, N. Azarnia, Lily Waiyee Lee, Pascual Daza-Ramirez
2006· article· en· Anti-Cancer Drugs· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
107
citations
fundno affunlabeled
Cytochrome P450 Protocols
Phillips R. Ian, Shephard A. Elizabeth
2005· book· en· Humana Press eBooks· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
102
citations
affunlabeled
Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response
Nan Soon Wong, Robert Buckman, Mark Clemons, Shailendra Verma, Susan Dent, Maureen Trudeau +9 more
2009· article· en· Journal of Clinical Oncology· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
84
citations
affunlabeled
Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
Harry D. Bear, Gong Tang, Priya Rastogi, Charles E. Geyer, André Robidoux, James N. Atkins +14 more
2013· article· en· Obstetrical & Gynecological Survey· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
81
citations
affno abstractunlabeled
A Phase 2 study of perifosine in advanced or metastatic breast cancer
Natasha B. Leighl, Susan Dent, Mark Clemons, Theodore A. Vandenberg, Richard Tozer, David Warr +5 more
2007· article· en· Breast Cancer Research and Treatment· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
77
citations
affunlabeled
Open-label phase III randomized controlled trial comparing taxane-based chemotherapy (Tax) with lapatinib (L) or trastuzumab (T) as first-line therapy for women with HER2+ metastatic breast cancer: Interim analysis (IA) of NCIC CTG MA.31/GSK EGF 108919.
Karen A. Gelmon, Frances Boyle, Bella Kaufman, David Huntsman, Alexey Manikhas, Angelo Di Leo +11 more
2012· article· en· Journal of Clinical Oncology· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
68
citations

How this was built: Screen · Findings · About